FDA Orange Book · active-ingredient family
Ethambutol hydrochloride
Ethambutol hydrochloride is approved as 1 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:MYAMBUTOL · NDA 016320
1
Brand (NDA)
3
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| MYAMBUTOLRLD×4 | KANCHAN HLTHCARE | NDA 016320 | AB | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (3)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ETHAMBUTOL HYDROCHLORIDE×2 | LUPIN | ANDA 078939 | AB | Jun 17, 2009 | |
| ETHAMBUTOL HYDROCHLORIDE | BARR | ANDA 076057 | — | Nov 26, 2001 | |
| ETHAMBUTOL HYDROCHLORIDE×2 | EPIC PHARMA LLC | ANDA 075095 | AB | Nov 30, 1999 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Ethambutol hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

